Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ raptor resources limited

Actually, now that I think about it.The health industries where...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 54 Last

Share
Profile

Follow
ChampKind01

42 Posts.

94

06/08/21

10:19

Post #: 55077069
Share

Originally posted by ChampKind01: ↑

Curios as to why there is some negativity surrounding the monthly subscription model? Particularly if there is a usage based trigger at certain points. There is so much flexibility in this model, not to mention scalability.

e.g. 1 year deal @ $X for Y amount of usages per month - IF Y amount of usages is exceeded within the month, then a premium is paid for the excess usages OR the client is lifted up to a higher tier in the pricing model.

Simple to administer and account for on both sides of the fence and would give the Resapp team some assurity when planning and managing server loads and other computational resources.

Have seen this tiered pricing model work well in other health related industries where its hard to forecast volume, case by case complexity and resource consumption.

So to me subscription model doesn't necessarily translate to less revenue in the short or long term. That said I am sure that medgate and alodokter would be getting pretty sweet deals in the short term, but it doesn't take away from the validity of the model.

Keen to hear opposing thoughts though.

Expand

Actually, now that I think about it.
The health industries where i observed similar models in action had an insurer OR payer involved in the transaction....

Wonder if this is Mike Connells broader health industry / medibank experience flowing through...?

RAP Price at posting: 4.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ZER

Zeta Resources seeks to resolve the Panoramic takeover story

The market's shrugged at China's stimulus measures all year. Why is this one different?

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

4DX

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

NAM

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The winners & losers on market if negative gearing were gone

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 69 more messages in this thread...

First 54 Last

Add RAP (ASX) to my watchlist

Actually, now that I think about it.The health industries where...

Top Stories

Zeta Resources seeks to resolve the Panoramic takeover story

The market's shrugged at China's stimulus measures all year. Why is this one different?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The winners & losers on market if negative gearing were gone

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News